Lidothol Es System
Product Images NDC 80425-0561

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lidothol Es (NDC 80425-0561). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lidocaine (Asset 1)

FDA Label Image

Menthol (Asset 2)

FDA Label Image

Figure1 (Asset 3)

FDA Label Image

Figure2 (Asset 4)

This text provides a proposed metabolic pathway of menthol, including its breakdown into various compounds like para-Menthane-3,7-diol, para-Menthane-3,8-diol, and Menthol-9-carboxylic acid, which are excreted through urine, feces, and O-glucuronide. It also mentions Enterophepatic circulation as part of the pathway.*

FDA Label Image

Lidothol Es Kit (Lidothol Es)

Not available.*

FDA Label Image

Di Table (Di Table)

FDA Label Image

Table1 (Table1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.